Robert J. Gould

2023 - Fulcrum Therapeutics

In 2023, Robert J. Gould earned a total compensation of $424.5K as Former Interim President and Chief Executive Officer at Fulcrum Therapeutics, a 259% increase compared to previous year.

Compensation breakdown

Option Awards$76,404
Salary$300,000
Other$48,097
Total$424,501

Gould received $300K in salary, accounting for 71% of the total pay in 2023.

Gould also received $76.4K in option awards and $48.1K in other compensation.

Rankings

In 2023, Robert J. Gould's compensation ranked 2,187th out of 2,907 executives tracked by ExecPay. In other words, Gould earned more than 24.8% of executives.

ClassificationRankingPercentile
All
2,187
out of 2,907
25th
Division
Manufacturing
1,244
out of 1,599
22nd
Major group
Chemicals And Allied Products
745
out of 901
17th
Industry group
Drugs
727
out of 864
16th
Industry
Pharmaceutical Preparations
522
out of 622
16th
Source: SEC filing on April 19, 2024.

Gould's colleagues

We found five more compensation records of executives who worked with Robert J. Gould at Fulcrum Therapeutics in 2023.

2023

Alex Sapir

Fulcrum Therapeutics

Chief Executive Officer

2023

Curtis Oltmans

Fulcrum Therapeutics

Chief Legal Officer

2023

Mel Hayes

Fulcrum Therapeutics

Executive Vice President, Patient Affairs

2023

Alan Musso

Fulcrum Therapeutics

Chief Financial Officer

2023

Bryan Stuart

Fulcrum Therapeutics

Chief Executive Officer

News

You may also like